WASHINGTON, D.C. – Following Rite Aid, Walgreens, and CVS Pharmacy announcing that they plan to become certified to dispense the chemical abortion drug mifepristone, Reps. Earl L. “Buddy” Carter (R-GA) and Chris Smith (R-NJ) led 36 House Republicans in a letter calling on the companies to protect the health and safety of women and unborn children.
In the letter, the members write: “We… Read more »
WASHINGTON, D.C. - Reps. Earl L. "Buddy" Carter (R-GA), Lisa Blunt Rochester (D-DE), Nicole Malliotakis (R-NY), and Jake Auchincloss (D-MA) introduced the Protecting Patients Against PBM Abuses Act to protect patients and pharmacies from harmful pharmacy benefit manager (PBM) practices that make high-quality health care inaccessible and unaffordable.
The bill… Read more »
WASHINGTON, D.C. – Reps. Earl L. "Buddy" Carter (R-GA), Darren Soto (D-FL), Carol Miller (R-WV), and Matt Cartwright (D-PA) today reintroduced a bill to make the U.S. pharmaceutical supply chain less dependent on China and other foreign adversaries.
According to the Food and Drug Administration, approximately 72 percent of active pharmaceutical ingredients (API) used in the U.S. drug… Read more »
ATLANTA, GA -- The 2023 Rx and Illicit Drug Summit featured a congressional panel on day two of the 12th annual conference led by U.S. Rep. Hal Rogers (KY-05), Dean of the House, who launched the national summit to help combat America's deadly epidemic. Congressman Rogers was joined by Reps. Earl L. "Buddy" Carter (R-GA), David Trone (D-MD), Matt Cartwright (D-PA), and Andrew Clyde… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Henry Cuellar (D-TX), and Chairman of the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party Mike Gallagher (R-WI) today introduced the bipartisan Pausing Enhanced Pandemic Pathogen Research Act to ban taxpayer dollars from funding gain-of-function research for five years, allowing… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) successfully lobbied the Food and Drug Administration (FDA) today to increase access to Emergent Biosolution’s life-saving opioid overdose reversal nasal spray, sold under the brand name Narcan, for use without a prescription.
Naloxone nasal spray is a safe, easy to use treatment that is proven “to reduce medical emergencies, drug… Read more »
WASHINGTON, D.C. - Reps. Earl L. “Buddy” Carter (R-GA), Elissa Slotkin (D-MI), Chrissy Houlahan (D-PA), and Gus Bilirakis (R-FL) officially launched the bipartisan Domestic Pharmaceutical Manufacturing Caucus for the 118th Congress.
The caucus will focus on advancing legislation that incentivizes more domestic production for essential medicines to reduce… Read more »
WASHINGTON, D.C. - Rep. Earl L. “Buddy” Carter (R-GA), Rep. Vicente Gonzalez (D-TX), House Republican Conference Chair Rep. Elise Stefanik (R-NY), Rep. Deborah Ross (D-NC), Rep. Rick Allen (R-GA), and Rep. Jake Auchincloss (D-MA) today introduced bipartisan legislation to end spread pricing in Medicaid programs, which leads to low reimbursement rates for pharmacies and artificially raises… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Yvette Clarke (D-NY), and Pete Sessions (R-TX) this week introduced the bipartisan Dental and Optometric Care Access (DOC Access) Act to provide fairness in contracts between health care providers and vision and dental insurers, thereby increasing the quality of care for patients and eliminating anti-competitive practices.
Current… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Bruce Westerman (R-AR), Jared Golden (D-ME), and Dutch Ruppersberger (D-MD) introduced the Patients’ Right to Know Their Medication Act of 2023 to ensure that rural Americans and seniors have access to important information about their prescription medications and to protect the jobs of hardworking Georgians.
It is common… Read more »
